Mike McNicholas is a Consultant Orthopaedic Surgeon at Liverpool University Hospitals Broadgreen, where he has a regional referral elective knee surgery practice treating all aspects of soft tissue knee pathology and sports injuries, with arthroscopy and ligament reconstruction, articular cartilage resurfacing, osteotomy and primary partial and total knee replacements. He has an Honorary Consultant contract in Manchester where he co-chairs the NorthWest Regional Autologous Chondrocyte Implantation and Joint Preservation service for its 7 million population.
He was elected President of the UK Biological Knee Society in 2020. He was Honorary Professor at the University of Salford 2006 to 2018, Honorary Senior Lecturer Division of Cell Matrix Biology and Regenerative Medicine, University of Manchester
since 2019 and in Liverpool from 2014 to 2020 and was a member of the University of Leeds EPSRC Optimising Knee Therapies Advisory Board 2017-21. He is a member of the International Cartilage Regeneration and Joint Preservation Society General Board and Chair of the ICRS Patient Registry Steering Committee.
He is a clinician advisor to NICE, associate editor and reviewer for several orthopaedic journals. He has written 16 book chapters, 24 Invited Editorials, over 49 peer reviewed publications, over 145 National and International Podium and over 100 Poster Presentations. He is faculty for train the trainer, training assessment in the clinical environment and advanced arthroscopy courses of the Royal College of Surgeons and regularly invited faculty at national and international joint preservation, ligament reconstruction and arthroplasty surgery meetings.
He is involved in international collaborative clinical and basic science research, mainly related to knee disorders and has won awards for this. Current research interests include graphene and stem cell applications in knee injury; ligament reconstruction, osteotomy, cartilage repair and arthroplasty outcomes, and the treatment of focal articular cartilage defects and early arthritis using novel implants.